Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

ChromaDex Corporation (CDXC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.9500+0.1900 (+6.88%)
At close: 04:00PM EST
2.9500 0.00 (0.00%)
After hours: 04:00PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
MACD

MACD

Previous Close2.7600
Open2.8700
Bid2.9600 x 800
Ask3.1900 x 3200
Day's Range2.8500 - 3.1300
52 Week Range2.7500 - 23.6600
Volume647,355
Avg. Volume332,324
Market Cap201.46M
Beta (5Y Monthly)1.64
PE Ratio (TTM)N/A
EPS (TTM)-0.4250
Earnings DateMar 08, 2022 - Mar 14, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est14.80
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for CDXC

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • ChromaDex Corporation
    CDMO: Lowering target price to $20.00AVID BIOSERVICES INC has an Investment Rating of HOLD; a target price of $20.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more
  • Benzinga

    ChromaDex Shares Gain On Niagen Supply Pact With US-Based Provider Of Dietary Supplements

    ChromaDex Corp (NASDAQ: CDXC) has announced a supply agreement with Designs for Health, a U.S.-based manufacturer of premium dietary supplements for healthcare practitioners (HCPs). ChromaDex's proprietary healthy aging ingredient Niagen will be added to multi-ingredient Designs for Health formulas. The Company says that Niagen is the world's first and only FDA-safety reviewed and patented form of nicotinamide riboside. The new products will be available exclusively through the Company's extensi

  • Business Wire

    ChromaDex and Designs for Health Partner for New Product Development on Niagen®

    LOS ANGELES, January 20, 2022--ChromaDex Corp. (NASDAQ:CDXC) today announced a supply agreement with Designs for Health, a U.S.-based manufacturer of premium dietary supplements for healthcare practitioners (HCPs). ChromaDex’s proprietary healthy aging ingredient Niagen®, the world’s first and only FDA-safety reviewed and patented form of nicotinamide riboside, will be added to multi-ingredient Designs for Health formulas. The new products will be available exclusively through the company’s exte

  • Simply Wall St.

    How Much Of ChromaDex Corporation (NASDAQ:CDXC) Do Insiders Own?

    The big shareholder groups in ChromaDex Corporation ( NASDAQ:CDXC ) have power over the company. Large companies...

Advertisement
Advertisement